Influence of Resistance Training Experience and Mental Imagery on Corticospinal Excitability and Inhibition

Sponsor
University of Central Florida (Other)
Overall Status
Recruiting
CT.gov ID
NCT03889548
Collaborator
(none)
125
1
2
46.8
2.7

Study Details

Study Description

Brief Summary

This study will utilize transcranial magnetic stimulation (TMS) to examine the effects of mental imagery in resistance-trained versus untrained men and women. In randomized order, each participant will perform a mental imagery task or a control condition as TMS is used to study corticospinal excitability.

Condition or Disease Intervention/Treatment Phase
  • Other: Mental Imagery
N/A

Detailed Description

Kinesthetic mental imagery is a technique that has previously been utilized to modulate neural signaling to the limbs in the absence of any mechanical movement of the limb. Kinesthetic imagery tasks require an individual to imagine they are maximally contracting a target muscle group. Previous investigations have shown mental imagery tasks to increase maximal strength of the limb and even attenuate strength loss during periods of immobilization. Similarly, corticospinal excitability, which indicates the ease in which the cortex can stimulate muscular contraction, has also been shown to increase during mental imagery tasks. These adaptations have been attributed to the role of the cortex as a critical determinant of strength and the potent cortical stimulus posed by mental imagery.

Mental imagery and resistance training have both shown to provide a positive impact on muscle strength. However, the interplay between a mental imagery task and resistance training experience has yet to be fully investigated in terms of their impact on corticospinal excitability and inhibition. To our knowledge, no study has examined the effect of resistance training experience on corticospinal excitability and inhibition during a mental imagery task. Thus, the purpose of this study is to determine if resistance trained and untrained participants experience differences in corticospinal excitability and inhibition during kinesthetic mental imagery.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
125 participants
Allocation:
Randomized
Intervention Model:
Crossover Assignment
Intervention Model Description:
Within-subjects design with mental imagery and control conditions performed in random orderWithin-subjects design with mental imagery and control conditions performed in random order
Masking:
Single (Outcomes Assessor)
Primary Purpose:
Basic Science
Official Title:
Influence of Resistance Training Experience on the Efficacy of Mental Imagery in Modulating Corticospinal Excitability and Inhibition: A Pilot Study
Actual Study Start Date :
Feb 7, 2019
Anticipated Primary Completion Date :
Jan 1, 2023
Anticipated Study Completion Date :
Jan 1, 2023

Arms and Interventions

Arm Intervention/Treatment
Experimental: Mental Imagery

Other: Mental Imagery
Immediately after determination of the resting motor threshold and pre-test measurements, the TMS administrator will leave the room so as to be blinded to the treatment condition of the participant. At this time the participant will be given instructions regarding the mental imagery protocol from a separate investigator who will not be blinded to the condition. During the mental imagery protocol, participants will be instructed to close their eyes and imagine they are maximally contracting the muscles in their forearm and imagine that they are making their wrist flex and that they are pushing maximally against a hand grip in their hand. This will be a kinesthetic imagery task, in which they are urging their muscles to contract maximally.

No Intervention: Control

Outcome Measures

Primary Outcome Measures

  1. Corticospinal Excitability [Greater than or equal to 24 hours to 7 days between visits.]

    Peak-to-peak amplitude of the motor evoked potential of the first dorsal interosseous at 130% of resting motor threshold

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 35 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Over the previous six months, participant has performed at least three resistance training sessions per week or

  • Over the previous six months, participant has refrained from resistance training entirely.

Exclusion Criteria:
  • Do not meet the resistance training experience requirements of either group

  • Neuromuscular disease (e.g. Parkinson's, MS, ALS)

  • Metabolic disease (e.g. diabetes, thyroid disorder, metabolic syndrome)

  • Arthritis in the upper limbs (hands, arms, shoulders)

  • Trouble using or controlling one's muscles

  • History of cancer

  • History of stroke

  • History of heart attack

  • Use of an assistive walking device or other mobility aids

  • Physician mandated contraindication to exercise within the last 6 months

  • Epilepsy or history of convulsions/seizures

  • History of fainting or syncope

  • History of head trauma that was diagnosed as concussion or was associated with loss of consciousness

  • History of hearing problems or tinnitus

  • Cochlear implants

  • Implanted metal in the brain, skull, or elsewhere in the body

  • Implanted neurotransmitter

  • Cardiac pacemaker or intracardiac lines

  • Medication infusion device

  • Past problems with brain stimulation

  • Past problems with MRI

  • Use of muscle relaxants or benzodiazepines

  • Allergy to rubbing alcohol

  • Any other health related illnesses that would prohibit a participant from physical performance testing

  • Lack of transportation to and from the laboratory

  • Any permanent / non-removable jewelry or metal fixtures

Contacts and Locations

Locations

Site City State Country Postal Code
1 Central Florida Research Park; Partnership 1 Building; UCF Neuromuscular Plasticity Laboratory Orlando Florida United States 32826

Sponsors and Collaborators

  • University of Central Florida

Investigators

  • Principal Investigator: Matt S Stock, Ph.D., School of Kinesiology and Physical Therapy

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Matt Stock, Assistant Professor, University of Central Florida
ClinicalTrials.gov Identifier:
NCT03889548
Other Study ID Numbers:
  • 00000170
First Posted:
Mar 26, 2019
Last Update Posted:
Aug 19, 2022
Last Verified:
Aug 1, 2022
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No

Study Results

No Results Posted as of Aug 19, 2022